{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:02:05Z","timestamp":1790600525759,"version":"4.1.0"},"reference-count":161,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":270,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intravenous ketamine is a rapid-acting intervention for treatment-resistant depression (TRD) in adults with major depressive disorder and bipolar disorder (BD). While efficacy is established, a comprehensive integration of clinical, neurophysiological, biomarker, metabolic, and cognitive predictors remains lacking, limiting precision CNS-targeted therapy. To synthesize recent evidence on multimodal predictors of intravenous ketamine response in TRD and propose a preliminary clinical framework to guide personalized treatment. Following PRISMA guidelines, Scopus, PubMed, EMBASE, and MEDLINE were searched for English-language, peer-reviewed studies published within the last 5 years. Eligible studies included adults receiving intravenous ketamine for depressive disorders. Data were descriptively synthesized to identify consistent predictors, evidence clusters, and research gaps. The review included 150 studies. Key predictors of ketamine response included baseline depressive severity, comorbid anxiety, atypical depression and sleep phenotypes, inflammatory and neuroplastic biomarkers (eg, monocyte count, BDNF), metabolic factors (BMI, vitamin B12), genetic\/epigenetic variants, neurophysiological signatures (EEG, TMS, fMRI connectivity), cognitive performance, and early symptomatic improvement. Integrative analysis suggests that glutamatergic, circadian, and inflammatory mechanisms interact to shape interindividual variability. Limitations include methodological heterogeneity and scarce long-term outcome data. Intravenous ketamine response in TRD is multifactorial, reflecting clinical phenotype, CNS biomarkers, neurophysiology, metabolism, and genetics. This review proposes a preliminary research framework and pilot clinical questionnaire intended to facilitate future investigation of individualized treatment approaches. However, most proposed predictors remain exploratory and require prospective validation before clinical implementation.<\/jats:p>","DOI":"10.1017\/s1092852926101187","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:48:30Z","timestamp":1790599710000},"source":"Crossref","is-referenced-by-count":0,"title":["Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders"],"prefix":"10.1017","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-3901","authenticated-orcid":false,"given":"Magda","family":"Malewska-Kasprzak","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02zbb2597","id-type":"ROR","asserted-by":"publisher"}],"name":"Poznan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rybakowski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02zbb2597","id-type":"ROR","asserted-by":"publisher"}],"name":"Poznan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dmitrzak-Weglarz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02zbb2597","id-type":"ROR","asserted-by":"publisher"}],"name":"Poznan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"S1092852926101187_r51","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4413"},{"key":"S1092852926101187_r74","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13870"},{"key":"S1092852926101187_r75","first-page":"CD011612","article-title":"Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder","volume":"2021","author":"Dean","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"S1092852926101187_r81","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12165"},{"key":"S1092852926101187_r141","doi-asserted-by":"publisher","DOI":"10.2196\/41013"},{"key":"S1092852926101187_r70","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-025-06918-4"},{"key":"S1092852926101187_r88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119477"},{"key":"S1092852926101187_r50","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19r12859"},{"key":"S1092852926101187_r140","article-title":"Pharmacokinetics, safety, and tolerability of (R)-ketamine hydrochloride injection, a novel rapid-acting antidepressant, in healthy Chinese subjects","volume":"18","author":"Wang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"S1092852926101187_r79","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18020138"},{"key":"S1092852926101187_r89","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02761-x"},{"key":"S1092852926101187_r4","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13734"},{"key":"S1092852926101187_r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.03.013"},{"key":"S1092852926101187_r153","doi-asserted-by":"publisher","DOI":"10.5114\/fpn.2024.140848"},{"key":"S1092852926101187_r131","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.70038"},{"key":"S1092852926101187_r31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1415505"},{"key":"S1092852926101187_r73","first-page":"9","article-title":"The level of vitamin B12 as a factor of efficacy of ketamine infusion in bipolar depression","volume":"32","author":"Malewska","year":"2016","journal-title":"Pharmacotherapy in Psychiatry and Neurology"},{"key":"S1092852926101187_r129","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13101358"},{"key":"S1092852926101187_r80","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05939-z"},{"key":"S1092852926101187_r121","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03027-2"},{"key":"S1092852926101187_r139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104344"},{"key":"S1092852926101187_r46","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03180-8"},{"key":"S1092852926101187_r93","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109838"},{"key":"S1092852926101187_r109","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001946"},{"key":"S1092852926101187_r150","article-title":"Safety and tolerability of ketamine use in treatment-resistant bipolar depression patients with regard to central nervous system symptomatology: literature review and analysis","volume":"56","author":"W\u0142odarczyk","year":"2020","journal-title":"Medicina (Lithuania)"},{"key":"S1092852926101187_r98","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2025.112001"},{"key":"S1092852926101187_r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110126"},{"key":"S1092852926101187_r85","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-021-01377-2"},{"key":"S1092852926101187_r149","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2024.276"},{"key":"S1092852926101187_r59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.003"},{"key":"S1092852926101187_r103","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111095"},{"key":"S1092852926101187_r136","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040568"},{"key":"S1092852926101187_r134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.08.047"},{"key":"S1092852926101187_r161","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.01.017"},{"key":"S1092852926101187_r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.10.031"},{"key":"S1092852926101187_r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2025.07.016"},{"key":"S1092852926101187_r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.12.036"},{"key":"S1092852926101187_r69","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01093-2"},{"key":"S1092852926101187_r12","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa089"},{"key":"S1092852926101187_r47","article-title":"Clinical effectiveness of intravenous racemic ketamine infusions in a large community sample of patients with treatment-resistant depression, suicidal ideation, and generalized anxiety symptoms: a retrospective chart review","volume":"83","author":"Oliver","year":"2022","journal-title":"A Retrospective Chart Review Journal of Clinical Psychiatry"},{"key":"S1092852926101187_r53","article-title":"A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression","volume":"13","author":"Zheng","year":"2022a","journal-title":"Front Psych"},{"key":"S1092852926101187_r25","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf052.202"},{"key":"S1092852926101187_r158","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2023.102387"},{"key":"S1092852926101187_r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.03.114"},{"key":"S1092852926101187_r30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157500"},{"key":"S1092852926101187_r96","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001305"},{"key":"S1092852926101187_r144","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111213"},{"key":"S1092852926101187_r155","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/97335"},{"key":"S1092852926101187_r151","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S325000"},{"key":"S1092852926101187_r119","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116691"},{"key":"S1092852926101187_r101","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.800015"},{"key":"S1092852926101187_r143","article-title":"Investigation of serum BDNF levels in alcohol withdrawal syndrome with and without other medical co-morbidities","author":"Malewska-Kasprzak","year":"2024","journal-title":"Alcohol"},{"key":"S1092852926101187_r112","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00203-1"},{"key":"S1092852926101187_r43","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1776699"},{"key":"S1092852926101187_r71","first-page":"1113","article-title":"Ketamine\u2014undrawn lines between medical and recreational use\u2014implications for clinical practice","volume":"33","author":"Jonovska","year":"2021","journal-title":"Psychiatr Danub"},{"key":"S1092852926101187_r72","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001149"},{"key":"S1092852926101187_r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2017.03.008"},{"key":"S1092852926101187_r107","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1498952"},{"key":"S1092852926101187_r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0080"},{"key":"S1092852926101187_r56","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-00864-9"},{"key":"S1092852926101187_r154","doi-asserted-by":"publisher","DOI":"10.1159\/000520146"},{"key":"S1092852926101187_r133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.11.090"},{"key":"S1092852926101187_r19","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-021-01264-w"},{"key":"S1092852926101187_r118","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115865"},{"key":"S1092852926101187_r62","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116355"},{"key":"S1092852926101187_r17","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/189494"},{"key":"S1092852926101187_r157","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116921"},{"key":"S1092852926101187_r146","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1214972"},{"key":"S1092852926101187_r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.001"},{"key":"S1092852926101187_r128","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14060583"},{"key":"S1092852926101187_r99","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12640"},{"key":"S1092852926101187_r37","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2022.2138444"},{"key":"S1092852926101187_r77","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001317"},{"key":"S1092852926101187_r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173228"},{"key":"S1092852926101187_r57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.03.048"},{"key":"S1092852926101187_r135","doi-asserted-by":"publisher","DOI":"10.1177\/20451253251392817"},{"key":"S1092852926101187_r125","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220216"},{"key":"S1092852926101187_r10","doi-asserted-by":"publisher","DOI":"10.1038\/nature25509"},{"key":"S1092852926101187_r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100383"},{"key":"S1092852926101187_r76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1176\/ajp.154.3.426","article-title":"Folate, vitamin B12, and homocysteine in major depressive disorder","volume":"154","author":"Fava","year":"1997","journal-title":"Am J Psychiatry"},{"key":"S1092852926101187_r156","first-page":"416","article-title":"Assessing the efficacy of ketamine as an add-on to antidepressant therapy for depression","volume":"10","author":"Kumar","year":"2021","journal-title":"International Journal of Life Sciences Biotechnology and Pharma Research"},{"key":"S1092852926101187_r26","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00897-2"},{"key":"S1092852926101187_r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.07.089"},{"key":"S1092852926101187_r120","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25m15789"},{"key":"S1092852926101187_r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.03.009"},{"key":"S1092852926101187_r5","first-page":"VC06","article-title":"Efficacy of ketamine as an adjuvant to antidepressants in the treatment of depression","volume":"15","author":"Solunke","year":"2021","journal-title":"J Clin Diagn Res"},{"key":"S1092852926101187_r32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914810"},{"key":"S1092852926101187_r54","article-title":"Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression","volume":"13","author":"Zheng","year":"2022b","journal-title":"Front Psych"},{"key":"S1092852926101187_r60","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00641-1"},{"key":"S1092852926101187_r108","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020173"},{"key":"S1092852926101187_r122","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-4124-6"},{"key":"S1092852926101187_r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.03.006"},{"key":"S1092852926101187_r123","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2024.18"},{"key":"S1092852926101187_r142","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000002060"},{"key":"S1092852926101187_r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.02.005"},{"key":"S1092852926101187_r160","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2025.2607086"},{"key":"S1092852926101187_r104","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03722-8"},{"key":"S1092852926101187_r52","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13216"},{"key":"S1092852926101187_r55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.02.032"},{"key":"S1092852926101187_r91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120133"},{"key":"S1092852926101187_r100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.028"},{"key":"S1092852926101187_r115","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0570-x"},{"key":"S1092852926101187_r117","first-page":"396","article-title":"A comparison between single and double-dose intravenous ketamine Administration in Bipolar Mood Disorder: a double-blind controlled clinical trial","volume":"18","author":"Talaei","year":"2023","journal-title":"Iran J Psychiatry"},{"key":"S1092852926101187_r38","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211014320"},{"key":"S1092852926101187_r113","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08698"},{"key":"S1092852926101187_r152","first-page":"164","article-title":"Ketamine infusions administered solely by psychiatric staff","volume":"119","author":"Ithman","year":"2022","journal-title":"Mo Med"},{"key":"S1092852926101187_r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.01.059"},{"key":"S1092852926101187_r111","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00730-9"},{"key":"S1092852926101187_r92","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.33038"},{"key":"S1092852926101187_r116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104902"},{"key":"S1092852926101187_r124","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01757-7"},{"key":"S1092852926101187_r159","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2025.2505770"},{"key":"S1092852926101187_r58","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2024.2391456"},{"key":"S1092852926101187_r36","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001663"},{"key":"S1092852926101187_r114","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2024.2441304"},{"key":"S1092852926101187_r27","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S273287"},{"key":"S1092852926101187_r33","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05716-0"},{"key":"S1092852926101187_r84","article-title":"The functional connectivity of the middle frontal cortex predicts ketamine\u2019s outcome in major depressive disorder","volume":"16","author":"Zhang","year":"2022","journal-title":"Front Neurosci"},{"key":"S1092852926101187_r147","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00637-x"},{"key":"S1092852926101187_r95","article-title":"Effect of ketamine on limbic GABA and glutamate: a human in vivo multivoxel magnetic resonance spectroscopy Study","volume":"11","author":"Silberbauer","year":"2020","journal-title":"Front Psych"},{"key":"S1092852926101187_r49","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120954048"},{"key":"S1092852926101187_r105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.165"},{"key":"S1092852926101187_r11","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01442-3"},{"key":"S1092852926101187_r148","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211011021"},{"key":"S1092852926101187_r44","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01712-0"},{"key":"S1092852926101187_r15","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13284"},{"key":"S1092852926101187_r86","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.13211"},{"key":"S1092852926101187_r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2024.02.772"},{"key":"S1092852926101187_r34","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyad045"},{"key":"S1092852926101187_r132","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.132"},{"key":"S1092852926101187_r137","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.70136"},{"key":"S1092852926101187_r67","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41386-020-00892-5","article-title":"ACNP 59(th) annual meeting: poster session III","volume":"45","author":"Badathala","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"S1092852926101187_r6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1222939"},{"key":"S1092852926101187_r138","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-024-00420-x"},{"key":"S1092852926101187_r39","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000658"},{"key":"S1092852926101187_r65","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-024-02358-w"},{"key":"S1092852926101187_r97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.04.015"},{"key":"S1092852926101187_r64","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e31824f8296"},{"key":"S1092852926101187_r90","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02451-0"},{"key":"S1092852926101187_r48","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-0644-9"},{"key":"S1092852926101187_r78","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2017.1297834"},{"key":"S1092852926101187_r82","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.70102"},{"key":"S1092852926101187_r126","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.12434"},{"key":"S1092852926101187_r9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1684\/mrh.2024.0534","article-title":"Magnesium level and impulsivity during ketamine administration for treatment-resistant mood disorders","volume":"37","author":"S\u0142upski","year":"2024","journal-title":"Magnes Res"},{"key":"S1092852926101187_r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.2185"},{"key":"S1092852926101187_r130","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001524"},{"key":"S1092852926101187_r127","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26217"},{"key":"S1092852926101187_r66","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114321"},{"key":"S1092852926101187_r145","article-title":"Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: a retrospective study of off-label, at-home use","volume":"13","author":"Hassan","year":"2022","journal-title":"Front Psych"},{"key":"S1092852926101187_r94","article-title":"Glutamate and GABA homeostasis and Neurometabolism in major depressive disorder","volume":"12","author":"Sarawagi","year":"2021","journal-title":"Front Psych"},{"key":"S1092852926101187_r87","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13232"},{"key":"S1092852926101187_r63","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25m15829"},{"key":"S1092852926101187_r8","doi-asserted-by":"publisher","DOI":"10.1038\/nature09742"},{"key":"S1092852926101187_r110","article-title":"Assessing cognitive function over time in patients with refractory chronic migraine who received ketamine infusions: a prospective, observational Study","author":"Vinokur","year":"2025","journal-title":"CNS Drugs"},{"key":"S1092852926101187_r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.04.014"},{"key":"S1092852926101187_r68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.09.029"},{"key":"S1092852926101187_r16","doi-asserted-by":"publisher","DOI":"10.1177\/10398562251328805"},{"key":"S1092852926101187_r61","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S339090"},{"key":"S1092852926101187_r106","doi-asserted-by":"publisher","DOI":"10.1002\/da.22975"},{"key":"S1092852926101187_r83","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyae059.240"},{"key":"S1092852926101187_r102","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-03789-3"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852926101187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:48:34Z","timestamp":1790599714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852926101187\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":161,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S1092852926101187"],"URL":"https:\/\/doi.org\/10.1017\/s1092852926101187","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e41"}}